A detailed history of Seven Eight Capital, LP transactions in Stryker Corp stock. As of the latest transaction made, Seven Eight Capital, LP holds 8,529 shares of SYK stock, worth $3.11 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
8,529
Holding current value
$3.11 Million
% of portfolio
0.29%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$315.94 - $371.96 $2.69 Million - $3.17 Million
8,529 New
8,529 $3.08 Million
Q1 2024

May 13, 2024

SELL
$293.94 - $358.71 $1.13 Million - $1.38 Million
-3,856 Reduced 72.52%
1,461 $522,000
Q4 2023

Feb 13, 2024

BUY
$253.85 - $299.46 $1.35 Million - $1.59 Million
5,317 New
5,317 $1.59 Million
Q2 2022

Aug 04, 2022

BUY
$194.09 - $276.37 $953,370 - $1.36 Million
4,912 New
4,912 $977,000
Q4 2021

Feb 14, 2022

SELL
$236.63 - $276.44 $4.85 Million - $5.67 Million
-20,500 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$248.9 - $280.09 $4.31 Million - $4.85 Million
17,324 Added 545.47%
20,500 $5.41 Million
Q2 2021

Aug 13, 2021

BUY
$242.95 - $267.0 $771,609 - $847,992
3,176 New
3,176 $825,000
Q1 2020

May 14, 2020

SELL
$126.5 - $225.1 $1.29 Million - $2.3 Million
-10,200 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$197.98 - $220.53 $2.02 Million - $2.25 Million
10,200 New
10,200 $2.14 Million
Q2 2019

Aug 12, 2019

SELL
$180.24 - $205.58 $4.69 Million - $5.35 Million
-26,000 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$152.46 - $198.0 $2.74 Million - $3.56 Million
18,000 Added 225.0%
26,000 $5.14 Million
Q4 2018

Feb 14, 2019

BUY
$145.0 - $178.65 $1.16 Million - $1.43 Million
8,000 New
8,000 $1.25 Million
Q3 2018

Oct 18, 2018

SELL
$163.25 - $177.68 $10.6 Million - $11.6 Million
-65,100 Closed
0 $0
Q2 2018

Aug 07, 2018

BUY
$155.17 - $179.78 $10.1 Million - $11.7 Million
65,100 New
65,100 $11 Million

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $138B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.